Dr. Georgios Pongas' Guide to CLL Care & Treatment Advances

Today, people with CLL are usually treated with targeted therapies, which are designed to attack specific features of cancer, rather than chemotherapy.

Researchers continue to look for better ways to manage CLL, including examining whether newer medications, like the next-generation BTK inhibitor pirtobrutinib, could play a role earlier in the course of treatment.

For many people, BTK inhibitors control CLL for years. They are taken as pills and, in most cases, are continued for as long as they are working and side effects remain manageable.

Since chronic lymphocytic leukemia (CLL) is often a chronic disease, many patients receive more than one treatment over the course of their lives.